menu search

Latest sci-fi news: a questionable superman fan casting draws skepticism and support as cad bane’s ‘star wars’ future — or lack thereof — comes into question

Star Wars is known for reusing popular old villains when at a loss for fresh content, which is sparking an interesting theory about Clone Wars and The...

May 2, 2023, 5:29 am

The fed's next move: pause, pivot or hike?

CNBC's Leslie Picker, Steve Liesman, and Mike Santoli along with The Wall Street Journal's Gunjan baner...

May 1, 2023, 3:18 pm

Day one biopharmaceuticals stock rallies as 1q results show the brain tumor treatment candidate producer is funded into 2025

Day One Biopharmaceuticals stock added more than 16% Monday afternoon after the company posted its first-quarter financial results.  The Bris...

May 1, 2023, 2:39 pm

Tempest to report early results from global randomized phase 1b/2 combination study of tpst-1120 in first-line hepatocellular carcinoma

Webcast Conference Call Friday, April 28, 2023, at 8:30 a.m. ET BRISbane, Calif., April 27, 2023 (GLOBE...

April 27, 2023, 8:58 pm

Tempest to report early results from global randomized phase 1b/2 combination study of tpst-1120 in first-line hepatocellular carcinoma

BRISbane, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clini...

April 27, 2023, 4:58 pm

Tempest announces tpst-1495 poster presentation at the 2023 asco annual meeting

BRISbane, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clin...

April 26, 2023, 10:41 pm

Day one announces abstracts accepted for presentation at the 2023 american society of clinical oncology (asco) annual meeting

New clinical data from registrational FIREFLY-1 study to be featured as an oral presentation Trial-in-progress poster from FIREFLY-2 and healthcare re...

April 26, 2023, 1:31 pm

Cutera, inc. to announce first quarter results on may 9, 2023

BRISbane, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a l...

April 24, 2023, 8:30 pm

Dollar firm on fed rate hike view, focus on china data

By Ankur banerjee SINGAPORE (Reuters) – The dollar eased on Tuesday after rallying overnight as stron...

April 18, 2023, 1:47 am

Dollar eases as us inflation cools

By Ankur banerjee SINGAPORE (Reuters) – The dollar was on the back foot on Thursday after cooler-than...

April 13, 2023, 1:46 am

Australian pm says inflation numbers ‘pleasing’ amid cost of living pressures

SYDNEY (Reuters) – Prime Minister Anthony Albanese said on Saturday he was pleased to see inflation r...

April 1, 2023, 1:00 am

Bae systems: aukus sub deal a 'long-term positive', says leading bank

The shortest of short lines early on Tuesday from Deutsche Bank asks more questions than it answers on BAE Systems PLC (LSE:BA.). Deutsche provided so...

March 14, 2023, 5:56 am

Britain’s sunak flies to us to advance three-way sub pact with australia

LONDON (Reuters) – British Prime Minister Rishi Sunak is flying to the United States on Sunday to meet U.S. President Joe Biden and Australian Prime...

March 11, 2023, 10:51 pm

South australia to be ‘big beneficiary’ of aukus: australian pm

SYDNEY (Reuters) – Australia’s Prime Minister Anthony Albanese said on Saturday that South Australi...

March 11, 2023, 5:36 am

Australia, india agree on strengthening defence partnerships

NEW DELHI (Reuters) – Australia has agreed to strengthen its defence partnerships with India, along with agreeing on the early completion of an econ...

March 10, 2023, 8:06 am

India, australia aim to boost economic, defence ties at first summit of pms

By Krishn Kaushik and Kirsty Needham NEW DELHI/SYDNEY (Reuters) – Australia’s Prime Minister Anthony Alban...

March 8, 2023, 7:51 am

Australian pm albanese to meet biden in us after india trip

SYDNEY (Reuters) – Australian Prime Minister Anthony Albanese said on Wednesday he will visit the Uni...

March 8, 2023, 1:51 am

Dollar steady before powell testimony; aussie slips

By Ankur banerjee SINGAPORE (Reuters) – The dollar was subdued on Tuesday ahead of testimony by Feder...

March 7, 2023, 9:13 am

Annexon reports fourth quarter and year-end 2022 financial results and reiterates anticipated milestones

Initial Clinical Data from Phase 2 Trial of ANX007 in Patients with Geographic Atrophy On-track for Mid-2023 Oral Small Molecule ANX1502, for Autoimmu...

March 6, 2023, 11:30 am


Search within

Pages Search Results: